Loading...
GD2 expression in breast cancer
Breast cancer (BC) is a heterogeneous disease, including different subtypes having diverse incidence, drug-sensitivity and survival rates. In particular, claudin-low and basal-like BC have mesenchymal features with a dismal prognosis. Disialoganglioside GD2 is a typical neuroectodermal antigen expre...
Na minha lista:
Udgivet i: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Impact Journals LLC
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5458232/ https://ncbi.nlm.nih.gov/pubmed/28415563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16363 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|